文献速递肝病消化道肿瘤与早癌

非酒精性脂肪性肝病与肝外癌症风险增加:观察性队列研究的荟萃分析

Non-alcoholic fatty liver disease and increased risk of incident extrahepatic cancers: a meta-analysis of observational cohort studies.
PubMed 文献 · Gut · 2021-03-08

NAFLD与胃肠道癌症风险增加近1.5至2倍相关,与肺癌、乳腺癌、妇科或泌尿系统癌症风险增加约1.2至1.5倍相关,且独立于年龄、性别、吸烟、肥胖、糖尿病等混杂因素。

要点

  • NAFLD患者肝外癌症风险中度增加,尤其胃肠道癌症、乳腺癌和妇科癌症。
  • 该关联独立于年龄、性别、吸烟、肥胖、糖尿病等潜在混杂因素。
  • 中位随访近6年,NAFLD与多种肝外癌症的长期风险相关。

核心结论

  • NAFLD与中位近6年的肝外癌症长期风险中度增加相关,尤其是胃肠道癌症、乳腺癌和妇科癌症。

研究设计与样本

  • NAFLD通过影像学技术或国际疾病分类代码诊断,无活检证实的NAFLD研究可用。
  • 采用随机效应模型进行荟萃分析。

主要发现

  • NAFLD与胃肠道癌症(食管癌、胃癌、胰腺癌或结直肠癌)风险增加近1.5至2倍显著相关。
  • NAFLD与肺癌、乳腺癌、妇科或泌尿系统癌症风险增加约1.2至1.5倍相关。
  • 所有风险均独立于年龄、性别、吸烟、肥胖、糖尿病或其他潜在混杂因素。
  • 大多数主要汇总分析的总体异质性相对较低,敏感性分析未改变这些发现,漏斗图未显示显著发表偏倚。

关键数值与推荐

  • NAFLD与胃肠道癌症风险增加近1.5至2倍相关,与肺癌、乳腺癌、妇科或泌尿系统癌症风险增加约1.2至1.5倍相关。

临床怎么用

  • 对于NAFLD患者,临床医生应意识到其肝外癌症(尤其是胃肠道癌症、乳腺癌和妇科癌症)的长期风险增加,可能需考虑相应的癌症筛查和监测。

局限性

  • 无活检证实的NAFLD研究可用,NAFLD诊断基于影像学或ICD代码。
  • 需要进一步研究以阐明NAFLD与癌症发展之间的复杂联系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: We performed a meta-analysis of observational studies to quantify the magnitude of the association between non-alcoholic fatty liver disease (NAFLD) and risk of extrahepatic cancers. DESIGN: We systematically searched PubMed, Scopus and Web of Science databases from the inception date to 30 December 2020 using predefined keywords to identify observational cohort studies conducted in individuals, in which NAFLD was diagnosed by imaging techniques or International Classification of Diseases codes. No studies with biopsy-proven NAFLD were available for the analysis. Meta-analysis was performed using random-effects modelling. RESULTS: We included 10 cohort studies with 182 202 middle-aged individuals (24.8% with NAFLD) and 8485 incident cases of extrahepatic cancers at different sites over a median follow-up of 5.8 years. NAFLD was significantly associated with a nearly 1.5-fold to twofold increased risk of developing GI cancers (oesophagus, stomach, pancreas or colorectal cancers). Furthermore, NAFLD was associated with an approximately 1.2-fold to 1.5-fold increased risk of developing lung, breast, gynaecological or urinary system cancers. All risks were independent of age, sex, smoking, obesity, diabetes or other potential confounders. The overall heterogeneity for most of the primary pooled analyses was relatively low. Sensitivity analyses did not alter these findings. Funnel plots did not reveal any significant publication bias. CONCLUSION: This large meta-analysis suggests that NAFLD is associated with a moderately increased long-term risk of developing extrahepatic cancers over a median of nearly 6 years (especially GI cancers, breast cancer and gynaecological cancers). Further research is required to decipher the complex link between NAFLD and cancer development.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Mantovani A, Petracca G, Beatrice G, et al. Non-alcoholic fatty liver disease and increased risk of incident extrahepatic cancers: a meta-analysis of observational cohort studies. Gut. 2021. PMID: 33685968. doi:10.1136/gutjnl-2021-324191

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。